Suppr超能文献

大麻成分可减少化学诱导和 scn1a 突变斑马鱼的癫痫发作行为。

Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.

机构信息

Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, United States of America.

Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, United States of America.

出版信息

Epilepsy Behav. 2020 Sep;110:107152. doi: 10.1016/j.yebeh.2020.107152. Epub 2020 Jun 22.

Abstract

Current antiepileptic drugs (AEDs) are undesirable for many reasons including the inability to reduce seizures in certain types of epilepsy, such as Dravet syndrome (DS) where in one-third of patients does not respond to current AEDs, and severe adverse effects that are frequently experienced by patients. Epidiolex, a cannabidiol (CBD)-based drug, was recently approved for treatment of DS. While Epidiolex shows great promise in reducing seizures in patients with DS, it is used in conjunction with other AEDs and can cause liver toxicity. To investigate whether other cannabis-derived compounds could also reduce seizures, the antiepileptic effects of CBD, Δ9-tetrahydrocannabinol (THC), cannabidivarin (CBDV), cannabinol (CBN), and linalool (LN) were compared in both a chemically-induced (pentylenetetrazole, PTZ) and a DS (scn1Lab) seizure models. Zebrafish (Danio rerio) that were either wild-type (Tupfel longfin) or scn1Lab (DS) were exposed to CBD, THC, CBDV, CBN, or LN for 24 h from 5 to 6 days postfertilization. Following exposure, total distance traveled was measured in a ViewPoint Zebrabox to determine if these compounds reduced seizure-like activity. Cannabidiol (0.6 and 1 μM) and THC (1 and 4 μM) significantly reduced PTZ-induced total distance moved. At the highest THC concentration, the significant reduction in PTZ-induced behavior was likely the result of sedation as opposed to antiseizure activity. In the DS model, CBD (0.6 μM), THC (1 μM), CBN (0.6 and 1 μM), and LN (4 μM) significantly reduced total distance traveled. Cannabinol was the most effective at reducing total distance relative to controls. In addition to CBD, other cannabis-derived compounds showed promise in reducing seizure-like activity in zebrafish. Specifically, four of the five compounds were effective in the DS model, whereas in the PTZ model, only CBD and THC were, suggesting a divergence in the mode of action among the cannabis constituents.

摘要

目前的抗癫痫药物(AEDs)由于多种原因不理想,包括无法减少某些类型的癫痫发作,例如 Dravet 综合征(DS),其中三分之一的患者对目前的 AEDs 没有反应,以及患者经常经历的严重不良反应。Epidiolex,一种基于大麻二酚(CBD)的药物,最近被批准用于治疗 DS。虽然 Epidiolex 在减少 DS 患者的癫痫发作方面显示出巨大的潜力,但它与其他 AED 联合使用,可能会导致肝毒性。为了研究其他大麻衍生化合物是否也能减少癫痫发作,比较了 CBD、Δ9-四氢大麻酚(THC)、大麻二酚(CBDV)、大麻酚(CBN)和芳樟醇(LN)在化学诱导(戊四氮,PTZ)和 DS(scn1Lab)癫痫模型中的抗癫痫作用。从受精后 5 到 6 天,将野生型(Tupfel longfin)或 scn1Lab(DS)斑马鱼暴露于 CBD、THC、CBDV、CBN 或 LN 中 24 小时。暴露后,在 ViewPoint Zebrabox 中测量总行进距离,以确定这些化合物是否减少癫痫样活动。CBD(0.6 和 1 μM)和 THC(1 和 4 μM)显著减少了 PTZ 诱导的总行进距离。在最高 THC 浓度下,PTZ 诱导行为的显著减少可能是镇静作用而不是抗癫痫作用的结果。在 DS 模型中,CBD(0.6 μM)、THC(1 μM)、CBN(0.6 和 1 μM)和 LN(4 μM)显著减少了总行进距离。与对照相比,大麻醇在减少总距离方面最有效。除了 CBD,其他大麻衍生化合物在减少斑马鱼的癫痫样活动方面显示出前景。具体来说,在 DS 模型中,五种化合物中有四种有效,而在 PTZ 模型中,只有 CBD 和 THC 有效,这表明大麻成分的作用模式存在差异。

相似文献

1
Cannabis constituents reduce seizure behavior in chemically-induced and scn1a-mutant zebrafish.
Epilepsy Behav. 2020 Sep;110:107152. doi: 10.1016/j.yebeh.2020.107152. Epub 2020 Jun 22.
2
Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
Epilepsy Behav. 2022 Feb;127:108514. doi: 10.1016/j.yebeh.2021.108514. Epub 2022 Jan 5.
4
Behavioral Comorbidities and Drug Treatments in a Zebrafish Model of Dravet Syndrome.
eNeuro. 2017 Aug 14;4(4). doi: 10.1523/ENEURO.0066-17.2017. eCollection 2017 Jul-Aug.
5
Source of cannabinoids: what is available, what is used, and where does it come from?
Epileptic Disord. 2020 Jan 1;22(S1):1-9. doi: 10.1684/epd.2019.1121.
6
Pharmacology of cannabinoids in the treatment of epilepsy.
Epilepsy Behav. 2017 May;70(Pt B):313-318. doi: 10.1016/j.yebeh.2016.11.016. Epub 2017 Jan 10.
8
Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15.
Addiction. 2015 Dec;110(12):1941-50. doi: 10.1111/add.13082. Epub 2015 Sep 18.
9
Cannabis sativa: Much more beyond Δ-tetrahydrocannabinol.
Pharmacol Res. 2020 Jul;157:104822. doi: 10.1016/j.phrs.2020.104822. Epub 2020 Apr 23.
10

引用本文的文献

1
Automated detection of complex zebrafish seizure behavior at scale.
Commun Biol. 2025 Jun 5;8(1):872. doi: 10.1038/s42003-025-08310-6.
2
The Anticonvulsant Effects of Different Cannabis Extracts in a Zebrafish Model of Epilepsy.
Biomolecules. 2025 May 1;15(5):654. doi: 10.3390/biom15050654.
3
Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder.
Int J Mol Sci. 2024 Oct 7;25(19):10768. doi: 10.3390/ijms251910768.
4
Induction of seizures and initiation of epileptogenesis by pilocarpine in zebrafish larvae.
Front Mol Neurosci. 2024 Aug 6;17:1418606. doi: 10.3389/fnmol.2024.1418606. eCollection 2024.
6
7
Zebrafish as a robust preclinical platform for screening plant-derived drugs with anticonvulsant properties-a review.
Front Mol Neurosci. 2023 Aug 28;16:1221665. doi: 10.3389/fnmol.2023.1221665. eCollection 2023.
8
Zebrafish as an Animal Model in Cannabinoid Research.
Int J Mol Sci. 2023 Jun 21;24(13):10455. doi: 10.3390/ijms241310455.
10
Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence.
Int J Mol Sci. 2022 Dec 19;23(24):16181. doi: 10.3390/ijms232416181.

本文引用的文献

1
Single and Synergistic Effects of Cannabidiol and Δ-9-Tetrahydrocannabinol on Zebrafish Models of Neuro-Hyperactivity.
Front Pharmacol. 2019 Mar 20;10:226. doi: 10.3389/fphar.2019.00226. eCollection 2019.
2
Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.
Drugs Today (Barc). 2019 Mar;55(3):177-196. doi: 10.1358/dot.2019.55.3.2909248.
3
Drug repurposing for Dravet syndrome in scn1Lab mutant zebrafish.
Epilepsia. 2019 Feb;60(2):e8-e13. doi: 10.1111/epi.14647. Epub 2019 Jan 20.
4
Preclinical safety and efficacy of cannabidivarin for early life seizures.
Neuropharmacology. 2019 Apr;148:189-198. doi: 10.1016/j.neuropharm.2019.01.002. Epub 2019 Jan 10.
5
Multigenerational consequences of early-life cannabinoid exposure in zebrafish.
Toxicol Appl Pharmacol. 2019 Feb 1;364:133-143. doi: 10.1016/j.taap.2018.12.021. Epub 2018 Dec 27.
7
A novel GABAergic dysfunction in human Dravet syndrome.
Epilepsia. 2018 Nov;59(11):2106-2117. doi: 10.1111/epi.14574. Epub 2018 Oct 11.
8
A prospective open-label trial of a CBD/THC cannabis oil in dravet syndrome.
Ann Clin Transl Neurol. 2018 Aug 1;5(9):1077-1088. doi: 10.1002/acn3.621. eCollection 2018 Sep.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验